Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped participants in a phase 2 clinical trial shed about 20% of their body ...

CHICAGO — Once-monthly maridebart cafraglutide resulted to significant weight loss at 1 year among adults with obesity, regardless of type 2 diabetes status, according to data from a phase 2 trial.

Researchers found that once-monthly maridebart cafraglutide led to substantial weight loss and improved glycemic control in adults with obesity, with or without diabetes, in a phase 2 randomized ...

Bradner said weight loss has been comparable to monthly doses, but more side effects have been reported. The next step for Amgen will be a phase 3 trial, which will run for 72 weeks.

Amgen's late-stage weight-loss drug MariTide is getting ready to enter the final stages of testing as the company enrolls patients in its phase 3 trial.The company announced Monday that it has ...

Bradner said weight loss has been comparable to monthly doses, but more side effects have been reported. The next step for Amgen will be a phase 3 trial, which will run for 72 weeks.

Metsera saw 8.4% placebo-adjusted weight loss at Day 36, advancing its push to challenge AbbVie, ... Metsera posts weight loss data for amylin analog, teeing up monthly GLP-1 combo plans.

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about the hot weather and what you need to know to protect yourself, the new ‘razor ...

A new trial has found that a weight loss drug taken monthly helps people to lose 20 percent of their body weight.. Other weight loss medications such as Ozempic, Wegovy and Mounjaro have become ...

The treatment led to an average 20 per cent weight loss in people living with obesity alone and a nearly 17 per cent mean weight loss in those living with obesity and type 2 diabetes, the study found.

A new trial has found that a weight loss drug taken monthly helps people to lose 20 percent of their body weight.. Other weight loss medications such as Ozempic, Wegovy and Mounjaro have become ...